Prosecution Insights
Last updated: May 29, 2026
Application No. 18/455,154

SIGNAL ATTENUATION-COMPENSATED AND PROJECTION RESOLVED OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY (SACPR-OCTA)

Final Rejection §102§103
Filed
Aug 24, 2023
Priority
Aug 24, 2022 — provisional 63/400,496
Examiner
THIRUGNANAM, GANDHI
Art Unit
2672
Tech Center
2600 — Communications
Assignee
Oregon Health & Science University
OA Round
2 (Final)
74%
Grant Probability
Favorable
3-4
OA Rounds
8m
Est. Remaining
86%
With Interview

Examiner Intelligence

Grants 74% — above average
74%
Career Allowance Rate
418 granted / 566 resolved
+11.9% vs TC avg
Moderate +12% lift
Without
With
+11.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 5m
Avg Prosecution
31 currently pending
Career history
601
Total Applications
across all art units

Statute-Specific Performance

§101
2.5%
-37.5% vs TC avg
§103
71.9%
+31.9% vs TC avg
§102
10.1%
-29.9% vs TC avg
§112
13.9%
-26.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 566 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Response to Arguments Applicant's arguments filed 1/14/2026 have been fully considered but they are not persuasive.. Applicant argues: PNG media_image1.png 322 570 media_image1.png Greyscale Examiner’s Response: While Jia does not explicitly recite “in backscatter light” in determining bulk motion, the Examiner contends that backscatter light is inherent required for determining bulk motion artifacts. As evidence, the Examiner provides “Time interval optimized optical coherence tomographic angiography for bulk motion suppression on human skin” which states: PNG media_image2.png 74 502 media_image2.png Greyscale And section 1 PNG media_image3.png 62 350 media_image3.png Greyscale PNG media_image4.png 52 336 media_image4.png Greyscale Additionally, the Examiner has provided another rejection of the independent claims which could be extended to all the dependent claims which were rejected under Jia. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1, and 12 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Hormel et al. (“Artifacts and artifact removal in optical coherence tomographic angiography”) Hormel discloses 1. A method comprising: receiving an optical coherence tomography angiography (OCTA) dataset; (Hormel, Abstract) determining, for respective voxels of the OCTA dataset, a proportion of in-situ flow signal based on a strength of attenuated projection artifacts in backscatter light; (Hormel, Section pg. 1121-1122, PNG media_image5.png 162 346 media_image5.png Greyscale and PNG media_image6.png 186 336 media_image6.png Greyscale PNG media_image7.png 192 342 media_image7.png Greyscale ….. PNG media_image8.png 92 340 media_image8.png Greyscale , EQN 2 discloses generating a flow signal; EQN 4 indicates that the flow signal acquires depth resolution based artifacts determined from scattering/backscattering light) adjusting respective values of the voxels based on the respective proportions to generate a signal attenuation-compensated projection-resolved OCTA (sacPR-OCTA) dataset; (Hormel, pg. 1123, “ PNG media_image9.png 190 340 media_image9.png Greyscale , see suppress background level) and generating a flow image based on the sacPR-OCTA dataset. (Hormel, See Fig. 1 & 2) Claim 12 is rejected under similar grounds as claim 1. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1, 5, 7, 11, 12, 16, 18 and 22 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Jia (PGPub 20180317851). Jia discloses 1. A method comprising: receiving an optical coherence tomography angiography (OCTA) dataset; (Jia, paragraph 47, OCTA dataset”) determining, for respective voxels of the OCTA dataset, a proportion of in-situ flow signal based on a strength of attenuated projection artifacts in backscatter light; (Jia, “[0047] At 112, the method 100 may include identifying vascular voxels of the OCTA dataset and/or the OCT dataset based on the estimated bulk motion. For example, the vascular voxels may be identified as voxels of the OCTA dataset having decorrelation values greater than a bulk motion decorrelation threshold and/or voxels of the OCT dataset having reflectance values greater than a bulk motion reflectance threshold. The voxels that do not meet the threshold may be considered nonvascular, and as such only contain bulk motion. The nonvascular voxels may be set to a decorrelation value of zero in the OCTA dataset.”, decorrelation values reads on the signal; Examiner Note: Bulk Motion artifacts occur in backscatter light) adjusting respective values of the voxels based on the respective proportions to generate a signal attenuation-compensated projection-resolved OCTA (sacPR-OCTA) dataset; (Jia, “[0047] At 112, the method 100 may include identifying vascular voxels of the OCTA dataset and/or the OCT dataset based on the estimated bulk motion. For example, the vascular voxels may be identified as voxels of the OCTA dataset having decorrelation values greater than a bulk motion decorrelation threshold and/or voxels of the OCT dataset having reflectance values greater than a bulk motion reflectance threshold. The voxels that do not meet the threshold may be considered nonvascular, and as such only contain bulk motion. The nonvascular voxels may be set to a decorrelation value of zero in the OCTA dataset. [0048] At 114, the method 100 may include subtracting estimated bulk motion velocity from the measured velocity in vascular voxels. The subtraction may be done in the velocity domain rather than the decorrelation domain.”) and generating a flow image based on the sacPR-OCTA dataset. (Jia, “[0049] At 116, the method 100 may include generating a flow image that is corrected for the estimated bulk motion. For example, as discussed above, the nonvascular voxels may be set to zero in the OCTA dataset. Additionally, the bulk motion velocity may be subtracted from the velocity of vascular voxels, and the corrected velocity may then be converted back to the decorrelation domain to generate a corrected decorrelation value. Alternatively, the flow image may be presented in the velocity domain.”) Jia discloses 5. The method of claim 1, further comprising: estimating a signal strength attenuation based on a reflectance strength; and determining the strength of attenuated projection artifacts based on the estimated signal strength attenuation. (Jia, “[0047] At 112, the method 100 may include identifying vascular voxels of the OCTA dataset and/or the OCT dataset based on the estimated bulk motion. For example, the vascular voxels may be identified as voxels of the OCTA dataset having decorrelation values greater than a bulk motion decorrelation threshold and/or voxels of the OCT dataset having reflectance values greater than a bulk motion reflectance threshold. The voxels that do not meet the threshold may be considered nonvascular, and as such only contain bulk motion. The nonvascular voxels may be set to a decorrelation value of zero in the OCTA dataset.”) Jia discloses 7. The method of claim 1, further comprising: detecting voxels that correspond to vessels; and compensating the values of the detected voxels based on the intensity of respective surrounding voxels prior to determining the proportion of in-situ flow signal for the respective voxels.(Jia, paragraph 82, “[0082] At each segment, a group of A-lines devoid of inner retinal flow voxels was selected. For this purpose, A-lines crossing large vessels were first identified by a binary large vessel mask of the en face angiogram and excluded from the following analysis. The mask was constructed by successively applying amplitude thresholding to remove the majority of capillary pixels, a morphological opening (erosion followed by dilation) to cleanup dispersed pixels, a Gaussian convolution filter to prevent holes in the middle of large vessels and a final binarization step. From the remaining A-lines, the first 10 percentile with the lowest decorrelation signal were selected, assuming these are composed by non-flow voxels only”) Jia discloses 11. The method of claim 1, further comprising obtaining the OCTA dataset by measuring motion contrast using an amplitude or a phase of repeated structural B-scans acquired at a same scan location.(Jia, paragraph 6, “0006] Optical coherence tomography angiography (OCTA) is a noninvasive blood flow imaging technique based on OCT that allows depth-resolved visualization of vascular maps with capillary resolution. Flow detection using OCT was first demonstrated by Doppler OCT, a technique that images blood flow by evaluating phase differences between adjacent depth profiles. More recent OCTA algorithms on the other hand, rely on mathematical operations (e.g. decorrelation, variance, difference, or ratio) that quantify variations in the phase and/or amplitude of OCT signal between at least two consecutive B-scans acquired at the same raster position. For example, the speckle variance method computes the amplitude decorrelation between consecutive cross-sectional OCT images to identify variations in the intensity of the OCT signal due to the motion of blood cells. An improved version of the speckle variance method is the split-spectrum amplitude-decorrelation angiography (SSADA) algorithm, which splits the interferogram before computing the amplitude decorrelation and later averages the flow images generated by all spectral splits, enhancing the signal-to-noise ratio. SSADA uses only two B-scans at each lateral position, which is beneficial for a reduced scanning time. Another OCTA method referred to as split-spectrum amplitude and phase-gradient angiography (SSAPGA) exploits the phase of the OCT signal besides the amplitude to further improve the flow image quality. Yet another alternative that utilizes the complex OCT signal is known as optical microangiography and relies on a modified Hilbert transform to distinguish moving scatterers from static scatterers. All of these modalities have one common purpose, to exploit the larger variation in OCT signal between scans due to moving scatterers in order to represent the pixels corresponding to blood vessels brighter than the pixels representing the surrounding tissue.”) Claim 12 is rejected under similar grounds as claim 1. Claim 16 is rejected under similar grounds as claim 5. Claim 18 is rejected under similar grounds as claim 7. Claim 22 is rejected under similar grounds as claim 11. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 9-10 20-21 is/are rejected under 35 U.S.C. 103 as being unpatentable over Jia in view of An (CN (114387174)) Jia discloses 9. The method of claim 1, But does not disclose “further comprising performing wavelet composition on the sacPR-OCTA dataset to suppress background noise” An discloses “further comprising performing wavelet composition on the sacPR-OCTA dataset to suppress background noise”.(An, “Therefore, the solution adopts double-tree complex wavelet transform. using double-tree complex wavelet transform noise reduction algorithm to reduce noise to the OCTA image. Specifically, firstly using double-tree complex wavelet transformation to the OCTA image to transform the image data into the wavelet domain, according to the set wavelet decomposition scale to obtain the corresponding number of multi-resolution scale layer, in the wavelet domain, the resolution ratio of each lifting layer corresponding to the wavelet coefficient will be reduced by 4 times, and for the wavelet coefficient in accordance with the direction characteristic distribution, the wavelet coefficient amplitude value will be increased. the noise-containing image increases with the resolution layer; the small wave coefficient value with directivity characteristic signal will become larger, and the small wave coefficient value corresponding to the randomly distributed noise is far less than the signal. The signal can be separated from the noise in the form of a threshold value to achieve the effect of image noise reduction.”) It would have been obvious to a person having ordinary skill in the art before the time of the effective filing date of the claimed invention of the instant application to use An’s method to remove noise before applying Jia’s algorithm. The suggestion/motivation for doing so would have been a better quality input image.. Further, one skilled in the art could have combined the elements as described above by known methods with no change in their respective functions, and the combination would have yielded nothing more than predictable results. Therefore, it would have been obvious to combine Jia with An to obtain the invention as specified in claim 9.. Jia in view of An discloses 10. The method of claim 9, wherein the wavelet decomposition is performed sequentially along a horizontal direction, a vertical direction, and a depth direction. (An, “Therefore, the solution adopts double-tree complex wavelet transform. using double-tree complex wavelet transform noise reduction algorithm to reduce noise to the OCTA image. Specifically, firstly using double-tree complex wavelet transformation to the OCTA image to transform the image data into the wavelet domain, according to the set wavelet decomposition scale to obtain the corresponding number of multi-resolution scale layer, in the wavelet domain, the resolution ratio of each lifting layer corresponding to the wavelet coefficient will be reduced by 4 times, and for the wavelet coefficient in accordance with the direction characteristic distribution, the wavelet coefficient amplitude value will be increased. the noise-containing image increases with the resolution layer; the small wave coefficient value with directivity characteristic signal will become larger, and the small wave coefficient value corresponding to the randomly distributed noise is far less than the signal. The signal can be separated from the noise in the form of a threshold value to achieve the effect of image noise reduction.”) Claim 20 is rejected under similar grounds as claim 9. Claim 21 is rejected under similar grounds as claim 10. Allowable Subject Matter Claims 2-4 , 6, 8, 13-15, 17 and 19 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to GANDHI THIRUGNANAM whose telephone number is (571)270-3261. The examiner can normally be reached M-F 8:30-5PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Sumati Lefkowitz can be reached at 571-272-3638. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /GANDHI THIRUGNANAM/ Primary Examiner, Art Unit 2672
Read full office action

Prosecution Timeline

Aug 24, 2023
Application Filed
Oct 01, 2025
Non-Final Rejection mailed — §102, §103
Jan 14, 2026
Response Filed
Apr 30, 2026
Final Rejection mailed — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12608812
SYSTEM AND METHOD FOR SEGMENTING THREE-DIMENSIONAL IMAGES OF PANCREASES AND TUMORS
2y 11m to grant Granted Apr 21, 2026
Patent 12597135
SYSTEMS AND METHODS FOR UPDATING A GRAPHICAL USER INTERFACE BASED UPON INTRAOPERATIVE IMAGING
2y 9m to grant Granted Apr 07, 2026
Patent 12561963
CROSS-MODALITY NEURAL NETWORK TRANSFORM FOR SEMI-AUTOMATIC MEDICAL IMAGE ANNOTATION
4y 4m to grant Granted Feb 24, 2026
Patent 12555291
METHOD FOR AUTOMATED REGULARIZATION OF HYBRID K-SPACE COMBINATION USING A NOISE ADJUSTMENT SCAN
3y 11m to grant Granted Feb 17, 2026
Patent 12541869
GRAIN FLAKE MEASUREMENT SYSTEM, GRAIN FLAKE MEASUREMENT METHOD, AND GRAIN FLAKE COLLECTION, MOVEMENT, AND MEASUREMENT SYSTEM
2y 5m to grant Granted Feb 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
74%
Grant Probability
86%
With Interview (+11.7%)
3y 5m (~8m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 566 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month